Jenne Kyle bought IONS
February 26, 2024 · Form 4 insider transaction
Jenne Kyle bought 65,203 shares of Ionis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 16 days after the transaction.
Direction
Acquired (buy-side)
Shares
65,203
Price
$0.00
Total value
N/A
InsiderJenne Kyle
Role—
SecurityNon-Qualified Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2024
Filing dateMarch 13, 2024
Shares owned after65,203
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Grant on 02/26/2024 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2020 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 02/26/2024. 25% of the shares subject to the option will vest and become exercisable on 02/26/2025. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.